BiomX Inc.
PHGE
$0.52
-$0.03-5.47%
AMEX
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -63.40% | 82.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -81.99% | -15.71% | |||
| Operating Income | 81.99% | 15.71% | |||
| Income Before Tax | -43.52% | -45.54% | |||
| Income Tax Expenses | -- | -66.67% | |||
| Earnings from Continuing Operations | -43.51% | -45.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -43.51% | -45.51% | |||
| EBIT | 81.99% | 15.71% | |||
| EBITDA | 90.64% | 17.18% | |||
| EPS Basic | -10.72% | -20.23% | |||
| Normalized Basic EPS | -478.13% | 74.84% | |||
| EPS Diluted | -10.72% | -20.23% | |||
| Normalized Diluted EPS | -478.13% | 74.84% | |||
| Average Basic Shares Outstanding | 30.19% | 21.02% | |||
| Average Diluted Shares Outstanding | 30.19% | 21.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||